Locally Advanced Metastatic Neoadjuvant (COG AALL1621)

Study Information

Status: Active, Not Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

Greater Sacramento Valley

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that has come back (relapsed) or does not respond to treatment (refractory). Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a toxic agent called ozogamicin. Inotuzumab attaches to CD22 positive cancer cells in a targeted way and delivers ozogamicin to kill them.

Location: SIMR (Sacramento/Valley Area)

Please contact: SIMR@sutterhealth.org about COG AALL1621

Principal Investigator

Yung Soon Yim, MD

Co-Investigator(s)

Saunders C. Hsu, M.D

Related Studies

Cancer Liquid Biopsy Monitoring Study

A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung c

Investigators: Deepti Behl, MD, Mohammed Kashani-Sabet, M.D.

COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs

Project goals: To understand impacts of COVID-19 on cancer care management (detection, diagnosis, treatment), pt-reported experience, and cancer care costs.

Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH

Stupski Serious Illness Program Evaluation

Evaluate palliative care projects at seven healthcare organizations in the SF Bay Area.

Investigator: Sylvia Sudat, PhD

Impact of COVID-19 on Cancer Care Management

Study will enhance understanding of cancer care management due to COVID-19.

Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.

Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions

Our objective is to examine “coverage, price, and reimbursement” for multigene tests broadly and for cancer-related indications.

Investigator: Su-Ying Liang, Ph.D.

Improving Cancer Care

Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.

Investigator: Su-Ying Liang, Ph.D.

Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)

Provide insights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with LDCT.

Investigator: Jiang Li, Ph.D., MPH

Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts

To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.

Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH, External PI, Principal Investigator

Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women

The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.

Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator

Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care

To examine how EHR data can expand understanding of breast cancer pathways--screening to dx and tx.

Patients and Visitors

My Health Online

Patient Resources

Billing and Insurance

Treatments and Services

Schedule a Visit

Get Care

Featured Services

Research and Education

Graduate Medical Education

Research

Education

About Us

Work at Sutter Health

About Sutter Health

Community

Careers